Insiders / Hastings Paul J

Hastings Paul J

CIK 1309702personinsider
Companies
2
First seen
Jan 8, 2026
Last activity
Jun 22, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
Nkarta, Inc. · NKTXCEO390,247562,0004
enGene Therapeutics Inc. · ENGNDirector31,0001

All securities held

3 positions · latest reported per filing
CompanySecuritySharesAs of
enGene Therapeutics Inc.Stock Option (Right to Buy)Derivative31,000Jun 16, 2026
Nkarta, Inc.Common Stock390,247Jun 18, 2026
Nkarta, Inc.Stock Option (right to buy)Derivative562,000Jan 6, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Jan 15, 2026SellNKTX
Nkarta, Inc.
Common Stock
$53.9K-26K
-6.26%
390,023
0.54% of shares
low
Jun 18, 2026SellNKTX
Nkarta, Inc.
Common Stock
$4.8K-2K
-0.45%
390,247
0.54% of shares
low
Jan 6, 2026GrantNKTX
Nkarta, Inc.
Common Stock
$0+94K
+29.19%
416,069
0.58% of shares
low
Jun 16, 2026GrantENGN
enGene Therapeutics Inc.
Stock Option (Right to Buy)
+31K
31,000
0.05% of shares
low
Jan 6, 2026GrantNKTX
Nkarta, Inc.
Stock Option (right to buy)
+562K
562,000
0.78% of shares
low